Express News | Jiangxi Synergy Pharmaceutical: Obtained the registration certificate for rivaroxaban tablets.

BreakingsNov 22 16:45

Nanjing Hicin Pharmaceutical (300584.SZ): Currently not involved in AI pharmaceuticals.

Gelonghui November 6th | Nanjing Hicin Pharmaceutical (300584.SZ) stated on the investor interaction platform that the company is currently not involved in AI pharmaceuticals.

Gelonghui FinanceNov 6 16:03

Express News | nanjing hicin pharmaceutical: Approval obtained for the increase in specifications of injection-grade Landiolol hydrochloride.

BreakingsNov 6 15:46

Nanjing Hicin Pharmaceutical (300584.SZ): Voglibose tablets pass generic drug consistency evaluation

On October 28th, Hicin Pharmaceutical (300584.SZ) announced that the company recently received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration. Voglibose tablets have passed the evaluation of generic drug quality and efficacy consistency. Voglibose tablets are oral hypoglycemic drugs, belonging to alpha-glucosidase inhibitors, which inhibit the alpha-glucosidase that breaks down disaccharides into monosaccharides in the intestines, thereby delaying the digestion and absorption of sugars, and improving postprandial hyperglycemia. The product is mainly used to improve postprandial hyperglycemia in diabetic patients (suitable for patients who have not achieved significant results with diet therapy and exercise therapy.

Gelonghui FinanceOct 28 15:45

Haichen Pharmaceutical: Report for the third quarter of 2024

SZSIOct 26 00:00 · Announcements

Nanjing Hicin Pharmaceutical (300584.SZ) plans to increase the capital of Anqing Huichen by 0.2 billion yuan and introduce 0.125 billion yuan of new investment.

Nanjing Hicin Pharmaceutical (300584.SZ) announced that its wholly-owned subsidiary, Anqing Huichen Technology Co., Ltd. ("Anqing Huichen...

Zhitong FinanceOct 11 15:58